GB9819999D0 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
GB9819999D0
GB9819999D0 GBGB9819999.5A GB9819999A GB9819999D0 GB 9819999 D0 GB9819999 D0 GB 9819999D0 GB 9819999 A GB9819999 A GB 9819999A GB 9819999 D0 GB9819999 D0 GB 9819999D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819999.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
London University College
Original Assignee
London University College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London University College filed Critical London University College
Priority to GBGB9819999.5A priority Critical patent/GB9819999D0/en
Publication of GB9819999D0 publication Critical patent/GB9819999D0/en
Application status is Ceased legal-status Critical

Links

GBGB9819999.5A 1998-09-14 1998-09-14 Treatment of cancer Ceased GB9819999D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9819999.5A GB9819999D0 (en) 1998-09-14 1998-09-14 Treatment of cancer

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9819999.5A GB9819999D0 (en) 1998-09-14 1998-09-14 Treatment of cancer
PCT/GB1999/003047 WO2000015780A1 (en) 1998-09-14 1999-09-14 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
CA 2343354 CA2343354A1 (en) 1998-09-14 1999-09-14 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
EP19990946334 EP1112356A1 (en) 1998-09-14 1999-09-14 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers
JP2000570307A JP2002525269A (en) 1998-09-14 1999-09-14 Its use for the treatment of inhibitors as well as breast and ovarian cancer Brn-3b
AU58748/99A AU5874899A (en) 1998-09-14 1999-09-14 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer

Publications (1)

Publication Number Publication Date
GB9819999D0 true GB9819999D0 (en) 1998-11-04

Family

ID=10838839

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819999.5A Ceased GB9819999D0 (en) 1998-09-14 1998-09-14 Treatment of cancer

Country Status (6)

Country Link
EP (1) EP1112356A1 (en)
JP (1) JP2002525269A (en)
AU (1) AU5874899A (en)
CA (1) CA2343354A1 (en)
GB (1) GB9819999D0 (en)
WO (1) WO2000015780A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE028632T2 (en) 2004-06-28 2016-12-28 Univ Western Australia Antisense oligonucleotides for inducing exon skipping and methods of use thereof
EP3428278A1 (en) 2008-10-24 2019-01-16 Sarepta Therapeutics, Inc. Multiple exon skipping compositions for dmd
EP3431603A1 (en) 2009-11-12 2019-01-23 The University Of Western Australia Antisense molecules and methods for treating pathologies
US9217148B2 (en) 2013-03-14 2015-12-22 Sarepta Therapeutics, Inc. Exon skipping compositions for treating muscular dystrophy
EP2968991A2 (en) 2013-03-15 2016-01-20 Sarepta Therapeutics, Inc. Improved compositions for treating muscular dystrophy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8548198A (en) * 1997-07-25 1999-02-16 Biovex Limited Use of transcription factor brn-3a

Also Published As

Publication number Publication date
CA2343354A1 (en) 2000-03-23
EP1112356A1 (en) 2001-07-04
AU5874899A (en) 2000-04-03
WO2000015780A1 (en) 2000-03-23
JP2002525269A (en) 2002-08-13

Similar Documents

Publication Publication Date Title
GB2335153B (en) Treatment of water
GB2351661B (en) Novel method of treatment
HK1111913A1 (en) ß-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
IL129352D0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
AU6479999A (en) Fracture treatment
EP1091745A4 (en) Treatment of hyperproliferative disorders
AU6147401A (en) Compositions and methods for the treatment of cancer
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
IL125592A (en) Water treatment
AU2606902A (en) Compositions and methods for the treatment of cancer
HK1039328A1 (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
GB9721506D0 (en) Treatment of diseases
IL139073D0 (en) Treatment of neuropathy
EG22787A (en) Treatment of coal
AP9700939A0 (en) Compounds and methods for the treatment of cancer
PL192433B1 (en) Malodour counteracting treatment
GB9818548D0 (en) Treatment of mucas hypersecretion
AU2212299A (en) Compositions and methods for the treatment of tumor
IL134718D0 (en) Treatment of conduct disorder
EP1181013A4 (en) Method and composition for the treatment of cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
EP1242060A4 (en) Treatment of metastatic disease
EP1063990A4 (en) Therapy of estrogen-associated disorders
EP0942742A4 (en) Therapeutic compositions for treatment of cancer
AU2630199A (en) Treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)